Published in Blood Weekly, January 6th, 2005
CTI markets Trisenox in the United States and Europe.
CTI also announced that it has signed agreements with 5 new distributors of Trisenox in Latin America, Eastern Europe, Israel, Turkey and South Africa. Earlier this year, the company announced that the U.S. Patent and Trademark office had issued a patent directed to Trisenox, extending CTI's marketing exclusivity...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.